Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | thymidylate kinase | 0.0195606 | 0.448021 | 0.5 |
Trypanosoma cruzi | thymidine kinase, putative | 0.011129 | 0.127835 | 0.285333 |
Trypanosoma brucei | thymidylate kinase, putative | 0.0195606 | 0.448021 | 1 |
Leishmania major | thymidylate kinase-like protein | 0.0195606 | 0.448021 | 1 |
Echinococcus multilocularis | transfer RNA-Ile | 0.0285127 | 0.787974 | 0.61588 |
Schistosoma mansoni | thymidine kinase | 0.0285127 | 0.787974 | 1 |
Echinococcus granulosus | solute carrier family 28 | 0.0340961 | 1 | 1 |
Echinococcus multilocularis | solute carrier family 28 | 0.0340961 | 1 | 1 |
Trypanosoma brucei | thymidylate kinase, putative | 0.0195606 | 0.448021 | 1 |
Echinococcus multilocularis | concentrative Na+ nucleoside cotransporter | 0.0340961 | 1 | 1 |
Plasmodium vivax | thymidylate kinase, putative | 0.0195606 | 0.448021 | 0.5 |
Mycobacterium tuberculosis | Thymidylate kinase Tmk (dTMP kinase) (thymidylic acid kinase) (TMPK) | 0.0195606 | 0.448021 | 0.5 |
Echinococcus granulosus | Thymidine kinase 2 mitochondrial | 0.0285127 | 0.787974 | 0.61588 |
Trichomonas vaginalis | thymidylate kinase, putative | 0.0195606 | 0.448021 | 1 |
Onchocerca volvulus | Putative thymidylate kinase | 0.0195606 | 0.448021 | 0.5 |
Echinococcus multilocularis | thymidine kinase | 0.0285127 | 0.787974 | 0.61588 |
Leishmania major | thymidine kinase, putative | 0.011129 | 0.127835 | 0.285333 |
Plasmodium falciparum | thymidylate kinase | 0.0195606 | 0.448021 | 0.5 |
Chlamydia trachomatis | thymidylate kinase | 0.0195606 | 0.448021 | 0.5 |
Echinococcus granulosus | thymidine kinase | 0.0285127 | 0.787974 | 0.61588 |
Trypanosoma cruzi | thymidine kinase, putative | 0.011129 | 0.127835 | 0.285333 |
Mycobacterium leprae | probable thymidylate kinase Tmk (dTMP KINASE) (THYMIDYLIC ACID KINASE) (TMPK) | 0.0195606 | 0.448021 | 0.5 |
Giardia lamblia | CDC8 | 0.0195606 | 0.448021 | 1 |
Echinococcus granulosus | Na+ dependent nucleoside transporter | 0.0340961 | 1 | 1 |
Entamoeba histolytica | Thymidylate kinase, putative | 0.0195606 | 0.448021 | 1 |
Brugia malayi | thymidylate kinase | 0.0195606 | 0.448021 | 0.5 |
Echinococcus multilocularis | sodium:nucleoside cotransporter 2 | 0.0222584 | 0.55047 | 0.185603 |
Treponema pallidum | thymidylate kinase (tmk) | 0.0195606 | 0.448021 | 0.5 |
Trypanosoma cruzi | thymidylate kinase, putative | 0.0195606 | 0.448021 | 1 |
Trypanosoma cruzi | thymidylate kinase, putative | 0.0195606 | 0.448021 | 1 |
Echinococcus multilocularis | thymidine kinase | 0.0285127 | 0.787974 | 0.61588 |
Toxoplasma gondii | thymidylate kinase | 0.0195606 | 0.448021 | 0.5 |
Loa Loa (eye worm) | thymidylate kinase | 0.0195606 | 0.448021 | 0.5 |
Trichomonas vaginalis | thymidylate kinase, putative | 0.0195606 | 0.448021 | 1 |
Echinococcus granulosus | concentrative Na nucleoside cotransporter | 0.0340961 | 1 | 1 |
Echinococcus granulosus | thymidine kinase | 0.0285127 | 0.787974 | 0.61588 |
Wolbachia endosymbiont of Brugia malayi | thymidylate kinase | 0.0195606 | 0.448021 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 1.6 uM | Antimalarial activity tested in vitro against Plasmodium falciparum. | ChEMBL. | 11882006 |
EC50 (functional) | = 1.6 uM | Antimalarial activity tested in vitro against Plasmodium falciparum. | ChEMBL. | 11882006 |
EC50 (functional) | = 14 uM | Mammalian cell cytotoxicity assessed against mouse mammary tumor FM3A cells | ChEMBL. | 11882006 |
EC50 (functional) | = 14 uM | Mammalian cell cytotoxicity assessed against mouse mammary tumor FM3A cells | ChEMBL. | 11882006 |
Selectivity ratio (functional) | = 9 | Mean of EC50 values for FM3A cells/ mean of EC50 values for P. falciparum | ChEMBL. | 11882006 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | 11882006 | |
Mus musculus | ChEMBL23 | 11882006 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.